Evidence map›Paper›PMID 42049398›Full record

ArticleIn vivo (Athens, Greece)

Does Irradiation of Pelvic Lymph Nodes Have an Impact on the Bladder Filling Status in Patients With High-risk Prostate Cancer?

Dirk Rades, Laura Doehring, Jan-Dirk Küter, Charlotte Kristiansen, Christine Vestergård-Madsen, Christian F Schulz, Stefan Janssen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dirk RadesDepartment of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
Laura DoehringDepartment of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany.
Jan-Dirk KüterDepartment of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck Campus, Lübeck, Germany.
Charlotte KristiansenDepartment of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
Christine Vestergård-MadsenDepartment of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
Christian F SchulzDepartment of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel Campus, Kiel, Germany.
Stefan JanssenDepartment of Radiation Oncology, University of Lübeck, Lübeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimIn patients irradiated for high-risk prostate cancer, bladder volumes should be ≥200 ml to reduce the risk of radiation cystitis. A prospective trial evaluates a reminder app to increase bladder filling during irradiation without pelvic lymph nodes (LN). This retrospective study investigates whether patients irradiated with LN can also be included in that trial. PATIENTS AND

methodsForty patients irradiated with (

resultsMean numbers of fractions with a volume <200 ml in the entire cohort, group A, and group B were 29.0±7.0, 28.8±7.6, and 29.2±6.6, respectively. The difference between groups A and B was not significant (

conclusionIrradiation of pelvic LN had no significant impact on the number of fractions for bladder volumes <200 ml. Patients irradiated with LN may be included in the prospective trial.

Indexed as

Lymph NodesPelvisProstatic NeoplasmsUrinary BladderAgedAged, 80 and overHumansLymphatic MetastasisMaleMiddle AgedRetrospective Studiesbladder fillinghigh-risk situationpelvic lymph nodesProstate cancerradiation therapy

Identifiers

PMID42049398
PMCPMC13133760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.